The Patent Finder

Theravectys

7 patents currently held · Updated Nov 21, 2026
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Aug 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 21, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 7 of 7

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,709,799Lentiviral gene transfer vectors and their medicinal applications
In force
 · USPTO record
In forceUSPTO record
US 8,420,104Lentiviral Gene Transfer Vectors and Their Medicinal Applications
In force
 · High confidence
In forceHigh confidence
US 9,752,160Use of Non-Subtype B Gag Proteins for Lentiviral Packaging
In force
 · High confidence
In forceHigh confidence
US 8,951,535Lentiviral vectors containing an MHC class I promoter
In force
 · USPTO record
In forceUSPTO record
US 9,657,311Lentiviral vectors containing an MHC class I, MHC class II, or B2 microglobulin upstream promoter sequence
In force
 · USPTO record
In forceUSPTO record
US 9,987,351Lentiviral vectors for generating immune responses against human T Lymphotrophic Virus Type 1
In force
 · USPTO record
In forceUSPTO record
US 10,864,265Lentiviral vectors for expression of hepatitis B virus (HBV) antigens
In force
 · USPTO record
In forceUSPTO record
Also on record, not counted in the 7: 3 patents in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

7 pending · 2 abandoned · 1 no status recorded

Showing 1 to 10 of 10, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/726,286Boosting SARS-COV-2 Immunity with a Lentiviral-Based Nasal VaccineJan 17, 2023Pending
18/706,610Lentiviral Vector for Expression of Human Papillomavirus (HPV) Antigens and Its Implementation in the Treatment of HPV Induced CancersNov 14, 2022Pending
18/285,553Lentiviral Vector, Lentiviral Particle for Treating Hepatitis B and Its Preparation Method and Application ThereofApr 7, 2022Pending
18/549,286Lentiviral Vectors Targeting Antigens to Mhc-Ii Pathway and Inducing Protective CD8+ and CD4+ T-Cell Immunity in a HostMar 11, 2022Pending
18/030,102Lentiviral Vectors Enabling Routing Antigens to Mhc-Ii Pathway and Inducing CD4+ and CD8+ T-Cell Responses in a HostOct 15, 2021Pending
18/245,987High Throughput Methods and Products for SARS-COV-2 Sero-Neutralization AssaySep 21, 2021Pending
18/005,146SARS-COV-2 Immunogenic Compositions, Vaccines, and MethodsJul 15, 2021Pending
16/931,986Lentiviral Vectors for Regulated Expression of a Chimeric Antigen Receptor MoleculeJul 17, 2020Abandoned
15/673,454Use of Non-Subtype B Gag Proteins for Lentiviral PackagingAug 10, 2017Abandoned
14/416,617Jul 25, 2013No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited